Gelonghui August 30th 丨Mingde Biotech (002932.SZ) announced its 2023 semi-annual report. Operating income for the reporting period was 538 million yuan, down 89.77% year on year; net profit attributable to shareholders of listed companies was 113 million yuan, down 95.92% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 35.031 million yuan, down 98.73% year on year; basic earnings per share were 0.49 yuan.
明德生物(002932.SZ)：上半年净利降95.92%至1.13亿元
Matilda Biotech (002932.SZ): Net profit for the first half of the year fell 95.92% to 113 million yuan
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.